Danish pharmaceutical company Novo Nordisk recently announced plans to spend approximately $1.2 billion to build a new ...

With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The American Society for Nutrition Foundation (ASNF) and the Novo Nordisk Foundation (NNF), two philanthropic 501(c)(3) organizations, have joined forces to launch new awards to celebrate excellence ...

Novo Nordisk ( (NVO) ) has provided an announcement.

New studies link diabetes drug Ozempic to increased risk of NAION, a rare eye condition causing vision loss. Danish Medicines ...

The European Union's drug regulator said it would review a potential link between Novo Nordisk's blockbuster diabetes drug, Ozempic, and a rare eye condition that causes vision loss after recent ...

Denmark's drug regulator asks EMA to investigate potential link between Novo Nordisk's diabetes drug Ozempic and rare eye ...